Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wadsworth, J. D.
Right arrow Articles by Collinge, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wadsworth, J. D.
Right arrow Articles by Collinge, J.
Related Collections
Right arrow Immunology
Right arrow Infectious Diseases
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 66:241-254 (2003)
© 2003 The British Council

Molecular and clinical classification of human prion disease

Jonathan DF Wadsworth, Andrew F Hill, Jonathan A Beck and John Collinge

MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College, London, UK

While rare in humans, the prion diseases have become an area of intense clinical and scientific interest. The recognition that variant Creutzfeldt-Jakob disease is caused by the same prion strain as bovine spongiform encephalopathy in cattle has dramatically highlighted the need for a precise understanding of the molecular biology of human prion diseases. Detailed clinical, pathological and molecular data from a large number of human prion disease cases have shown that distinct abnormal isoforms of prion protein are associated with prion protein gene polymorphism and neuropathological phenotypes. A molecular classification of human prion diseases seems achievable through characterisation of structural differences of the infectious agent itself.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. Yin, X. Fan, S. Yu, C. Li, and M.-S. Sy
Binding of Recombinant but Not Endogenous Prion Protein to DNA Causes DNA Internalization and Expression in Mammalian Cells
J. Biol. Chem., September 12, 2008; 283(37): 25446 - 25454.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. D. F. Wadsworth, S. Joiner, J. M. Linehan, M. Desbruslais, K. Fox, S. Cooper, S. Cronier, E. A. Asante, S. Mead, S. Brandner, et al.
Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice
PNAS, March 11, 2008; 105(10): 3885 - 3890.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. M. H. Tank, D. A. Harris, A. A. Desai, and H. L. True
Prion Protein Repeat Expansion Results in Increased Aggregation and Reveals Phenotypic Variability
Mol. Cell. Biol., August 1, 2007; 27(15): 5445 - 5455.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. M. Norstrom and J. A. Mastrianni
The Charge Structure of Helix 1 in the Prion Protein Regulates Conversion to Pathogenic PrPSc.
J. Virol., September 1, 2006; 80(17): 8521 - 8529.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. D. F. Wadsworth, S. Joiner, J. M. Linehan, S. Cooper, C. Powell, G. Mallinson, J. Buckell, I. Gowland, E. A. Asante, H. Budka, et al.
Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein
Brain, June 1, 2006; 129(6): 1557 - 1569.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. F. Hill, S. Joiner, J. A. Beck, T. A. Campbell, A. Dickinson, M. Poulter, J. D. F. Wadsworth, and J. Collinge
Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations
Brain, March 1, 2006; 129(3): 676 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
R. A. Moore, C. Herzog, J. Errett, D. A. Kocisko, K. M. Arnold, S. F. Hayes, and S. A. Priola
Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation
Protein Sci., March 1, 2006; 15(3): 609 - 619.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
A. Khalili-Shirazi, L. Summers, J. Linehan, G. Mallinson, D. Anstee, S. Hawke, G. S. Jackson, and J. Collinge
PrP glycoforms are associated in a strain-specific ratio in native PrPSc
J. Gen. Virol., September 1, 2005; 86(9): 2635 - 2644.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
J. Novakofski, M. S. Brewer, N. Mateus-Pinilla, J. Killefer, and R. H. McCusker
Prion biology relevant to bovine spongiform encephalopathy
J Anim Sci, June 1, 2005; 83(6): 1455 - 1476.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. -M. Rodriguez, K. Peoc'h, S. Haik, C. Bouchet, L. Vernengo, G. Manana, R. Salamano, L. Carrasco, M. Lenne, P. Beaudry, et al.
A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease
Neurology, April 26, 2005; 64(8): 1455 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Moudjou, E. Treguer, H. Rezaei, E. Sabuncu, E. Neuendorf, M. H. Groschup, J. Grosclaude, and H. Laude
Glycan-Controlled Epitopes of Prion Protein Include a Major Determinant of Susceptibility to Sheep Scrapie
J. Virol., September 1, 2004; 78(17): 9270 - 9276.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.